New data from Peregrine Pharmaceuticals, along with other recent research, suggests that surface proteins can be used to isolate cancer-specific exosomes to detect the presence of a tumor.
Exonics will use the funding to advance preclinical research from UT-Southwestern researcher Eric Olson on genome editing of DMD mutations in a mouse model.
UT-SWMC researcher Eric Olson will study dystrophin produced with CRISPR/Cas9 genome editing in a mouse model, as well as off-target effects.
Researchers link two genes to sleep regulation, according to Medical News Today.
In Science this week: convergent evolution in bird hemoglobin, and more.
The partners have a long-standing sponsored research agreement focused on phosphatidylserine, a signaling molecule found in tumor exosomes.
The peptide may be a new therapeutic target for heart failure patients and suggests that similar ncRNA-encoded proteins with important functions may exist.
The funding is part of a total of $16.6 million from CPRIT to support cancer research at and recruit scientists to the medical center.
The gift from the Hersch Foundation also will be used to create the Julie K. Hersch Chair in depression research and clinical care.
NEW YORK (GenomeWeb) – Using the CRISPR/Cas9 genome editing system, researchers from the University of Texas Southwestern Medical Center were able to prevent Duchenne muscular dystrophy in a mouse model of the disease.
A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.
The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.
In Nature this week: investigation into the genetics of medulloblastoma, and more.
A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.